CONTEXT: Prolongation of the electrocardiographic PR interval, known as first-degree atrioventricular block when the PR interval exceeds 200 milliseconds, is frequently encountered in clinical practice. OBJECTIVE: To determine the clinical significance of PR prolongation in ambulatory individuals. DESIGN, SETTING, AND PARTICIPANTS: Prospective, community-based cohort including 7575 individuals from the Framingham Heart Study (mean age, 47 years; 54% women) who underwent routine 12-lead electrocardiography. The study cohort underwent prospective follow-up through 2007 from baseline examinations in 1968-1974. Multivariable-adjusted Cox proportional hazards models were used to examine the associations of PR interval with the incidence of arrhythmic events and death. MAIN OUTCOME MEASURES: Incident atrial fibrillation (AF), pacemaker implantation, and all-cause mortality. RESULTS: During follow-up, 481 participants developed AF, 124 required pacemaker implantation, and 1739 died. At the baseline examination, 124 individuals had PR intervals longer than 200 milliseconds. For those with PR intervals longer than 200 milliseconds compared with those with PR intervals of 200 milliseconds or shorter, incidence rates per 10 000 person-years were 140 (95% confidence interval [CI], 95-208) vs 36 (95% CI, 32-39) for AF, 59 (95% CI, 40-87) vs 6 (95% CI, 5-7) for pacemaker implantation, and 334 (95% CI, 260-428) vs 129 (95% CI, 123-135) for all-cause mortality. Corresponding absolute risk increases were 1.04% (AF), 0.53% (pacemaker implantation), and 2.05% (all-cause mortality) per year. In multivariable analyses, each 20-millisecond increment in PR was associated with an adjusted hazard ratio (HR) of 1.11 (95% CI, 1.02-1.22; P = .02) for AF, 1.22 (95% CI, 1.14-1.30; P < .001) for pacemaker implantation, and 1.08 (95% CI, 1.02-1.13; P = .005) for all-cause mortality. Individuals with first-degree atrioventricular block had a 2-fold adjusted risk of AF (HR, 2.06; 95% CI, 1.36-3.12; P < .001), 3-fold adjusted risk of pacemaker implantation (HR, 2.89; 95% CI, 1.83-4.57; P < .001), and 1.4-fold adjusted risk of all-cause mortality (HR, 1.44, 95% CI, 1.09-1.91; P = .01). CONCLUSION: Prolongation of the PR interval is associated with increased risks of AF, pacemaker implantation, and all-cause mortality.
CONTEXT: Prolongation of the electrocardiographic PR interval, known as first-degree atrioventricular block when the PR interval exceeds 200 milliseconds, is frequently encountered in clinical practice. OBJECTIVE: To determine the clinical significance of PR prolongation in ambulatory individuals. DESIGN, SETTING, AND PARTICIPANTS: Prospective, community-based cohort including 7575 individuals from the Framingham Heart Study (mean age, 47 years; 54% women) who underwent routine 12-lead electrocardiography. The study cohort underwent prospective follow-up through 2007 from baseline examinations in 1968-1974. Multivariable-adjusted Cox proportional hazards models were used to examine the associations of PR interval with the incidence of arrhythmic events and death. MAIN OUTCOME MEASURES: Incident atrial fibrillation (AF), pacemaker implantation, and all-cause mortality. RESULTS: During follow-up, 481 participants developed AF, 124 required pacemaker implantation, and 1739 died. At the baseline examination, 124 individuals had PR intervals longer than 200 milliseconds. For those with PR intervals longer than 200 milliseconds compared with those with PR intervals of 200 milliseconds or shorter, incidence rates per 10 000 person-years were 140 (95% confidence interval [CI], 95-208) vs 36 (95% CI, 32-39) for AF, 59 (95% CI, 40-87) vs 6 (95% CI, 5-7) for pacemaker implantation, and 334 (95% CI, 260-428) vs 129 (95% CI, 123-135) for all-cause mortality. Corresponding absolute risk increases were 1.04% (AF), 0.53% (pacemaker implantation), and 2.05% (all-cause mortality) per year. In multivariable analyses, each 20-millisecond increment in PR was associated with an adjusted hazard ratio (HR) of 1.11 (95% CI, 1.02-1.22; P = .02) for AF, 1.22 (95% CI, 1.14-1.30; P < .001) for pacemaker implantation, and 1.08 (95% CI, 1.02-1.13; P = .005) for all-cause mortality. Individuals with first-degree atrioventricular block had a 2-fold adjusted risk of AF (HR, 2.06; 95% CI, 1.36-3.12; P < .001), 3-fold adjusted risk of pacemaker implantation (HR, 2.89; 95% CI, 1.83-4.57; P < .001), and 1.4-fold adjusted risk of all-cause mortality (HR, 1.44, 95% CI, 1.09-1.91; P = .01). CONCLUSION: Prolongation of the PR interval is associated with increased risks of AF, pacemaker implantation, and all-cause mortality.
Authors: Lisa A Freed; Emelia J Benjamin; Daniel Levy; Martin G Larson; Jane C Evans; Deborah L Fuller; Birgitta Lehman; Robert A Levine Journal: J Am Coll Cardiol Date: 2002-10-02 Impact factor: 24.094
Authors: Michael O Sweeney; Anne S Hellkamp; Kenneth A Ellenbogen; Arnold J Greenspon; Roger A Freedman; Kerry L Lee; Gervasio A Lamas Journal: Circulation Date: 2003-06-02 Impact factor: 29.690
Authors: Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Torbjorn Omland; Philip A Wolf; Ramachandran S Vasan Journal: N Engl J Med Date: 2004-02-12 Impact factor: 91.245
Authors: Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner Journal: Circulation Date: 2011-12-15 Impact factor: 29.690
Authors: David E Arnolds; Fang Liu; John P Fahrenbach; Gene H Kim; Kurt J Schillinger; Scott Smemo; Elizabeth M McNally; Marcelo A Nobrega; Vickas V Patel; Ivan P Moskowitz Journal: J Clin Invest Date: 2012-06-25 Impact factor: 14.808
Authors: Susan Cheng; Martin G Larson; Michelle J Keyes; Elizabeth L McCabe; Christopher Newton-Cheh; Daniel Levy; Emelia J Benjamin; Ramachandran S Vasan; Thomas J Wang Journal: Am J Cardiol Date: 2010-07-23 Impact factor: 2.778
Authors: Vincenzo Macri; Jennifer A Brody; Dan E Arking; William J Hucker; Xiaoyan Yin; Honghuang Lin; Robert W Mills; Moritz F Sinner; Steven A Lubitz; Ching-Ti Liu; Alanna C Morrison; Alvaro Alonso; Ning Li; Vadim V Fedorov; Paul M Janssen; Joshua C Bis; Susan R Heckbert; Elena V Dolmatova; Thomas Lumley; Colleen M Sitlani; L Adrienne Cupples; Sara L Pulit; Christopher Newton-Cheh; John Barnard; Jonathan D Smith; David R Van Wagoner; Mina K Chung; Gus J Vlahakes; Christopher J O'Donnell; Jerome I Rotter; Kenneth B Margulies; Michael P Morley; Thomas P Cappola; Emelia J Benjamin; Donna Muzny; Richard A Gibbs; Rebecca D Jackson; Jared W Magnani; Caroline N Herndon; Stephen S Rich; Bruce M Psaty; David J Milan; Eric Boerwinkle; Peter J Mohler; Nona Sotoodehnia; Patrick T Ellinor Journal: Circ Genom Precis Med Date: 2018-05
Authors: Jared W Magnani; Lei Zhu; Faye Lopez; Michael J Pencina; Sunil K Agarwal; Elsayed Z Soliman; Emelia J Benjamin; Alvaro Alonso Journal: Am Heart J Date: 2014-10-22 Impact factor: 4.749
Authors: Claudia Stöllberger; Daniel Gerger; Peter Jirak; Christian Wegner; Josef Finsterer Journal: Ann Noninvasive Electrocardiol Date: 2014-06-16 Impact factor: 1.468